Re-audit of bedside glucose monitoring of inpatients on glucocorticoids: have we improved?
DOI:
https://doi.org/10.15277/bjd.2021.279Keywords:
diabetes, glucocorticoids, hyperglycaemia, monitoringReferences
British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. London, 2020.
Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance. Endocrinol Metab Clin North Am 2014;43:75–102. https://doi.org/10.1016/j.ecl.2013.10.005
Narwani V, Swafe L, Stavraka C, Dhatariya K. How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoids? Clin Med 2014;14:327–8. https://doi.org/10.7861/clinmedicine.14-3-326a
Roberts A, James J, Dhatariya K, et al. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med 2018; 35:1011–17. https://doi.org/10.1111/dme.13675
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
